• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脂肪甘油三酯脂肪酶(PNPLA3)和单酰基甘油脂肪酶缺失协同增加小鼠体重增加并加重脂肪性肝炎。

Absence of Adiponutrin (PNPLA3) and Monoacylglycerol Lipase Synergistically Increases Weight Gain and Aggravates Steatohepatitis in Mice.

机构信息

Hans Popper Laboratory of Molecular Hepatology, Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, 1090 Vienna, Austria.

Center for Liver, Digestive and Metabolic Diseases, Departments of Pediatrics, University Medical Center Groningen, 9712 Groningen, The Netherlands.

出版信息

Int J Mol Sci. 2021 Feb 20;22(4):2126. doi: 10.3390/ijms22042126.

DOI:10.3390/ijms22042126
PMID:33672787
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7924608/
Abstract

Altered lipid metabolic pathways including hydrolysis of triglycerides are key players in the pathogenesis of nonalcoholic fatty liver disease (NAFLD). Whether adiponutrin (patatin-like phospholipase domain containing protein-3-PNPLA3) and monoacylglycerol lipase (MGL) synergistically contribute to disease progression remains unclear. We generated double knockout () mice lacking both and ; mice were compared to after a challenge by high-fat diet (HFD) for 12 weeks to induce steatosis. Serum biochemistry, liver transaminases as well as histology were analyzed. Fatty acid (FA) profiling was assessed in liver and adipose tissue by gas chromatography. Markers of inflammation and lipid metabolism were analyzed. Bone marrow derived macrophages (BMDMs) were isolated and treated with oleic acid. Combined deficiency of and resulted in weight gain on a chow diet; when challenged by HFD, mice showed increased hepatic FA synthesis and diminished beta-oxidation compared to mice exhibited more pronounced hepatic steatosis with inflammation and recruitment of immune cells to the liver associated with accumulation of saturated FAs. Primary BMDMs isolated from the mice showed increased inflammatory activities, which could be reversed by oleic acid supplementation. deficiency aggravates the effects of deletion on steatosis and inflammation in the liver under HFD challenge.

摘要

改变的脂质代谢途径,包括甘油三酯的水解,是非酒精性脂肪性肝病(NAFLD)发病机制中的关键因素。脂肪素(亲脂酶结构域包含蛋白 3-PNPLA3)和单酰基甘油脂肪酶(MGL)是否协同促进疾病进展尚不清楚。我们生成了缺乏 和 的双敲除()小鼠;将 小鼠与 小鼠进行比较,后者在高脂肪饮食(HFD)喂养 12 周后诱导脂肪变性。分析血清生化、肝转氨酶以及组织学。通过气相色谱法评估肝和脂肪组织中的脂肪酸(FA)谱。分析炎症和脂质代谢标志物。分离骨髓来源的巨噬细胞(BMDMs)并进行油酸处理。 和 联合缺失导致正常饮食时体重增加;当受到 HFD 挑战时,与 小鼠相比, 小鼠表现出增加的肝 FA 合成和减少的β氧化,表现出更明显的肝脂肪变性伴炎症和免疫细胞募集到肝脏,与饱和 FA 的积累相关。从 小鼠分离的原代 BMDMs 显示出增加的炎症活性,这可以通过油酸补充来逆转。在 HFD 挑战下, 缺失加重了 缺失对肝脂肪变性和炎症的影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a522/7924608/a66cdc591327/ijms-22-02126-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a522/7924608/ebf189cadbd3/ijms-22-02126-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a522/7924608/1131ad2b6804/ijms-22-02126-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a522/7924608/732fb7214147/ijms-22-02126-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a522/7924608/a66cdc591327/ijms-22-02126-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a522/7924608/ebf189cadbd3/ijms-22-02126-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a522/7924608/1131ad2b6804/ijms-22-02126-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a522/7924608/732fb7214147/ijms-22-02126-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a522/7924608/a66cdc591327/ijms-22-02126-g004.jpg

相似文献

1
Absence of Adiponutrin (PNPLA3) and Monoacylglycerol Lipase Synergistically Increases Weight Gain and Aggravates Steatohepatitis in Mice.脂肪甘油三酯脂肪酶(PNPLA3)和单酰基甘油脂肪酶缺失协同增加小鼠体重增加并加重脂肪性肝炎。
Int J Mol Sci. 2021 Feb 20;22(4):2126. doi: 10.3390/ijms22042126.
2
Lack of monoacylglycerol lipase prevents hepatic steatosis by favoring lipid storage in adipose tissue and intestinal malabsorption.缺乏单酰甘油脂肪酶通过促进脂肪组织的脂质储存和肠道吸收不良来预防肝脂肪变性。
J Lipid Res. 2019 Jul;60(7):1284-1292. doi: 10.1194/jlr.M093369. Epub 2019 May 2.
3
Shifts in dietary carbohydrate-lipid exposure regulate expression of the non-alcoholic fatty liver disease-associated gene PNPLA3/adiponutrin in mouse liver and HepG2 human liver cells.膳食碳水化合物-脂质暴露的变化调节非酒精性脂肪性肝病相关基因 PNPLA3/脂联素在小鼠肝脏和 HepG2 人肝细胞中的表达。
Metabolism. 2014 Oct;63(10):1352-62. doi: 10.1016/j.metabol.2014.06.016. Epub 2014 Jun 21.
4
Hepatocyte-specific deletion of adipose triglyceride lipase (adipose triglyceride lipase/patatin-like phospholipase domain containing 2) ameliorates dietary induced steatohepatitis in mice.肝细胞特异性缺失脂肪甘油三酯脂肪酶(脂肪甘油三酯脂肪酶/含patatin样磷脂酶结构域2)可改善小鼠饮食诱导的脂肪性肝炎。
Hepatology. 2022 Jan;75(1):125-139. doi: 10.1002/hep.32112. Epub 2021 Dec 4.
5
PNPLA3 p.I148M variant is associated with greater reduction of liver fat content after bariatric surgery.PNPLA3基因的p.I148M变异与减肥手术后肝脏脂肪含量的更大幅度降低有关。
Surg Obes Relat Dis. 2016 Dec;12(10):1838-1846. doi: 10.1016/j.soard.2016.06.004. Epub 2016 Jul 1.
6
Absence of adipose triglyceride lipase protects from hepatic endoplasmic reticulum stress in mice.脂肪甘油三酯脂肪酶缺失可保护小鼠肝脏内质网应激。
Hepatology. 2012 Jul;56(1):270-80. doi: 10.1002/hep.25601. Epub 2012 May 29.
7
The ménage à trois of autophagy, lipid droplets and liver disease.自噬、脂滴与肝脏疾病的三者关系。
Autophagy. 2022 Jan;18(1):50-72. doi: 10.1080/15548627.2021.1895658. Epub 2021 Apr 2.
8
Monoacylglycerol lipase deficiency affects diet-induced obesity, fat absorption, and feeding behavior in CB cannabinoid receptor-deficient mice.单酰甘油脂肪酶缺乏影响 CB 大麻素受体缺陷型小鼠的饮食诱导肥胖、脂肪吸收和摄食行为。
FASEB J. 2019 Feb;33(2):2484-2497. doi: 10.1096/fj.201801203R. Epub 2018 Sep 28.
9
PNPLA3 Expression Is Related to Liver Steatosis in Morbidly Obese Women with Non-Alcoholic Fatty Liver Disease.PNPLA3表达与患有非酒精性脂肪性肝病的病态肥胖女性的肝脏脂肪变性有关。
Int J Mol Sci. 2016 Apr 27;17(5):630. doi: 10.3390/ijms17050630.
10
Weight loss induced by bariatric surgery restores adipose tissue PNPLA3 expression.减重手术引起的体重减轻可恢复脂肪组织 PNPLA3 的表达。
Liver Int. 2017 Feb;37(2):299-306. doi: 10.1111/liv.13222. Epub 2016 Aug 29.

引用本文的文献

1
PNPLA3 I148M variant is the main driver of weight gain after hepatitis C cure.PNPLA3 I148M变异体是丙型肝炎治愈后体重增加的主要驱动因素。
Sci Rep. 2025 Jul 15;15(1):25543. doi: 10.1038/s41598-025-11085-9.
2
Exploring the role of genetic variations in NAFLD: implications for disease pathogenesis and precision medicine approaches.探讨遗传变异在非酒精性脂肪性肝病中的作用:对疾病发病机制和精准医学方法的启示。
Eur J Med Res. 2024 Mar 20;29(1):190. doi: 10.1186/s40001-024-01708-8.
3
Mouse models of nonalcoholic fatty liver disease (NAFLD): pathomechanisms and pharmacotherapies.

本文引用的文献

1
Monoacylglycerol lipase reprograms lipid precursors signaling in liver disease.单酰甘油脂肪酶重编程肝病中的脂质前体信号传导。
World J Gastroenterol. 2020 Jul 7;26(25):3577-3585. doi: 10.3748/wjg.v26.i25.3577.
2
The Role of Metabolic Lipases in the Pathogenesis and Management of Liver Disease.代谢脂肪酶在肝脏疾病发病机制和治疗中的作用。
Hepatology. 2020 Sep;72(3):1117-1126. doi: 10.1002/hep.31250.
3
MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease.MAFLD:代谢相关脂肪性肝病的共识驱动命名建议。
非酒精性脂肪性肝病(NAFLD)的小鼠模型:发病机制和药物治疗。
Int J Biol Sci. 2022 Sep 6;18(15):5681-5697. doi: 10.7150/ijbs.65044. eCollection 2022.
4
Stearoyl-CoA desaturase 1: A potential target for non-alcoholic fatty liver disease?-perspective on emerging experimental evidence.硬脂酰辅酶A去饱和酶1:非酒精性脂肪性肝病的潜在靶点?——基于新出现实验证据的观点
World J Hepatol. 2022 Jan 27;14(1):168-179. doi: 10.4254/wjh.v14.i1.168.
Gastroenterology. 2020 May;158(7):1999-2014.e1. doi: 10.1053/j.gastro.2019.11.312. Epub 2020 Feb 8.
4
Genetic contributions to NAFLD: leveraging shared genetics to uncover systems biology.遗传因素对非酒精性脂肪性肝病的影响:利用共同遗传学揭示系统生物学。
Nat Rev Gastroenterol Hepatol. 2020 Jan;17(1):40-52. doi: 10.1038/s41575-019-0212-0. Epub 2019 Oct 22.
5
Monoacylglycerol Lipase Inhibition Protects From Liver Injury in Mouse Models of Sclerosing Cholangitis.单酰甘油脂肪酶抑制可预防硬化性胆管炎小鼠模型的肝损伤。
Hepatology. 2020 May;71(5):1750-1765. doi: 10.1002/hep.30929. Epub 2019 Dec 30.
6
Dynamic interactions of ABHD5 with PNPLA3 regulate triacylglycerol metabolism in brown adipocytes.ABHD5 与 PNPLA3 的动态相互作用调节棕色脂肪细胞中的三酰基甘油代谢。
Nat Metab. 2019 May;1(5):560-569. doi: 10.1038/s42255-019-0066-3. Epub 2019 May 6.
7
I148M Variant Impairs Liver X Receptor Signaling and Cholesterol Homeostasis in Human Hepatic Stellate Cells.I148M 变体损害人肝星状细胞中的肝 X 受体信号传导和胆固醇稳态。
Hepatol Commun. 2019 Jul 15;3(9):1191-1204. doi: 10.1002/hep4.1395. eCollection 2019 Sep.
8
Human PNPLA3-I148M variant increases hepatic retention of polyunsaturated fatty acids.人 PNPLA3-I148M 变异增加多不饱和脂肪酸在肝脏中的蓄积。
JCI Insight. 2019 Aug 22;4(16):127902. doi: 10.1172/jci.insight.127902.
9
Lack of monoacylglycerol lipase prevents hepatic steatosis by favoring lipid storage in adipose tissue and intestinal malabsorption.缺乏单酰甘油脂肪酶通过促进脂肪组织的脂质储存和肠道吸收不良来预防肝脂肪变性。
J Lipid Res. 2019 Jul;60(7):1284-1292. doi: 10.1194/jlr.M093369. Epub 2019 May 2.
10
Bone marrow-derived macrophage contributes to fibrosing steatohepatitis through activating hepatic stellate cells.骨髓源性巨噬细胞通过激活肝星状细胞促进纤维脂肪性肝炎。
J Pathol. 2019 Aug;248(4):488-500. doi: 10.1002/path.5275. Epub 2019 May 7.